Inventor · disambiguated record
Ziad Mallat
Also filed as: MALLAT ZIAD
13 granted patents·15 pending applications·11 citations·filing 2001–2020
85Inventor score
Files withMALLAT ZIAD13INST NAT SANTE RECH MED5TEDGUI ALAIN3CHVATCHKO YOLANDE2INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)2
Top patents by PatentIndex Score
28 records- 0177US8361732B2Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2012·Granted Jan 29, 2013·2 cites·4 claims
- 0273US8383355B2Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2009·Granted Feb 26, 2013·3 cites·15 claims
- 0373US8324152B2Composition for the treatment of atherosclerosisTEDGUI ALAIN·Filed 2006·Granted Dec 4, 2012·3 cites·7 claims
- 0467US8163504B2Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventMALLAT ZIAD·Filed 2009·Granted Apr 24, 2012·2 cites·10 claims
- 0566US12144859B2B cell depleting agent for the treatment of atherosclerosisMALLAT ZIAD·Filed 2020·Granted Nov 19, 2024·0 cites·10 claims
- 0665US2012264146A1Combination of spla2 activity and lp(a) cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventMALLAT ZIAD·Filed 2009·Application pending·0 cites
- 0764US9688767B2Method of predicting survival time in myocardial infarction patients by measuring BAFF levelsINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE·Filed 2014·Granted Jun 27, 2017·1 cites·3 claims
- 0864US2015132771A1Combination of spla2 activity and lp(a) cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/eventINST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
- 0957US2019365890A1A B Cell Depleting Agent for the Treatment of AtherosclerosisMALLAT ZIAD·Filed 2019·Application pending·0 cites
- 1056US2013224215A1A B Cell Depleting Agent for the Treatment of AtherosclerosisMALLAT ZIAD·Filed 2013·Application pending·0 cites
- 1154US8586822B2Methods for producing a non human model for aortic aneurysmTHARAUX PIERRE LOUIS·Filed 2008·Granted Nov 19, 2013·0 cites·10 claims
- 1249US9592267B2Use of IL-18BP for treatment of peripheral vascular diseasesCHVATCHKO YOLANDE·Filed 2003·Granted Mar 14, 2017·0 cites·23 claims
- 1349US2015104463A1Methods and kits for predicting the risk of having a cardiovascular event in a subjectMALLAT ZIAD·Filed 2014·Application pending·0 cites
- 1446US2011275791A1A B Cell Depleting Agent for the Treatment of AtherosclerosisMALLAT ZIAD·Filed 2010·Application pending·0 cites
- 1546US2007249008A1Cardiovascular Prognostic and Diagnostic MarkerMALLAT ZIAD·Filed 2005·Application pending·0 cites
- 1645US9566313B2Method of treating peripheral vascular diseases using IL-18 inhibitorsCHVATCHKO YOLANDE·Filed 2010·Granted Feb 14, 2017·0 cites·6 claims
- 1744US8187818B2Use of sPLA2 activity for the diagnosis of a cardiovascular eventTEDGUI ALAIN·Filed 2007·Granted May 29, 2012·0 cites·9 claims
- 1844US7985409B2Tr1 cells for use in atherosclerosisINST NAT SANTE RECH MED·Filed 2004·Granted Jul 26, 2011·0 cites·17 claims
- 1943US9573997B2Method for use in the treatment of aneurysmINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2013·Granted Feb 21, 2017·0 cites·1 claims
- 2043US2012321650A1Composition for the treatment of atherosclerosisTEDGUI ALAIN·Filed 2012·Application pending·0 cites
- 2142US11752131B2Methods and pharmaceutical compositions for the treatment of obesityINST NAT SANTE RECH MED·Filed 2017·Granted Sep 12, 2023·0 cites·6 claims
- 2242US2004076628A1Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosisFiled 2001·Application pending·0 cites
- 2341US2014004540A1Methods and kits for predicting the risk of having a cardiovascular event in a subjectMALLAT ZIAD·Filed 2012·Application pending·0 cites
- 2439US2010256045A1Use of Measles Virus Nucleoprotein for Treating AtherosclerosisMALLAT ZIAD·Filed 2007·Application pending·0 cites
- 2538US2012311728A1Methods and pharmaceutical composition for the treatment of atherosclerosisMALLAT ZIAD·Filed 2010·Application pending·0 cites
- 2637US2015299763A1Spla2 cardiovascular prognostic and diagnostic markerI N S E R M INST NAT DE LA SANTE ET DE LA RECH MEDICALE·Filed 2015·Application pending·0 cites
- 2729US2012225427A1sPLA2 IIA Polymorphism Analysis for the Diagnosis/Prognosis of a Cardiovascular Disease/EventMALLAT ZIAD·Filed 2010·Application pending·0 cites
- 2825US2012076754A1Use of IL-17 Polypeptides for Use in the Prevention or Treatment of AtherosclerosisMALLAT ZIAD·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →